Helen Frances Baker

Title: Helen Frances Baker: Innovator in Antitumor Therapy and Sustained-Release Formulations

Introduction

Helen Frances Baker is a distinguished inventor based in Cambridge, GB. She has made significant contributions to the field of pharmaceuticals, particularly in antitumor therapy and drug formulation. With a total of three patents to her name, Baker's work has had a notable impact on medical treatments.

Latest Patents

Among her latest patents, one focuses on the use of the enantiomers of ifosfamide in antitumor therapy. This patent details how (R)-Ifosfamide is administered as a cytotoxic drug to minimize side effects, while (S)-Ifosfamide may be administered subsequently. Another significant patent pertains to a sustained-release formulation of d-threo-methylphenidate. This invention includes methods for treating disorders using a sustained-release formulation comprising d-threo-methylphenidate.

Career Highlights

Throughout her career, Helen Frances Baker has worked with notable companies such as Medeva Europe Limited and Chiroscience, Ltd. Her innovative approaches have contributed to advancements in pharmaceutical formulations and therapies.

Collaborations

Baker has collaborated with esteemed colleagues, including Julian Clive Gilbert and Brian Michael Adger. These partnerships have further enriched her research and development efforts.

Conclusion

Helen Frances Baker's contributions to the field of pharmaceuticals through her patents and collaborations highlight her role as a key innovator. Her work continues to influence medical treatments and drug formulations, showcasing the importance of innovation in healthcare.